The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappaB. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The initial event in IL-17R signaling is recruitment of Act1 (aka CIKS), a multifunctional signaling protein that also contains a SEFIR domain necessary for IL-17R-Act1 association”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“upon IL-17 signaling, Act1 rapidly recruits and ubiquitinates TNF-receptor associated factor (TRAF)6”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521 · cited 1×
“Because IL-17 has a critical function in neutrophilia through the upregulation of chemokines, which is important for the development of inflammatory diseases including coliti”
BackgroundDong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293 · cited 1×
“Because astrocytes are responsive to IL-17 and are important in the production of cytokines and chemokines during EA”
BackgroundTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Research works printed but not linked: 13
- Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226–229 (2003). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Iwakura, Y. & Ishigame, H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218–1222 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Weaver, A. et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668–1670 (2005). · DOI · Paper page
- Becher, B., Bechmann, I. & Greter, M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84, 532–543 (2006). · DOI · Paper page
- Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006). · DOI · Paper page
- Koenders, M.I. et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239–3247 (2005). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Han, Y., Wang, J., Zhou, Z. & Ransohoff, R.M. TGFβ1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30, 1–10 (2000). · DOI · Paper page
Cited by
Items 101–200 of 623
Cho, K., Suh, J. W., Lee, K. H., Kang, J. L., & Woo, S. (2011) · International Immunology · doi:10.1093/intimm/dxr110 · Cited by 161
Ubiquitin Makes Its Mark on Immune Regulation
Malynn, B. A., & Ma, A. (2010) · Immunity · doi:10.1016/j.immuni.2010.12.007 · Cited by 149
“In contrast to its role in B cell signaling, Act1 is a positive signaling regulator of IL-17-mediated responses in T cells by recruiting TAK1 and TRAF6 (Qian et al., 2007).”
BackgroundIL-17 and the Th17 lineage in systemic lupus erythematosus
Garrett-Sinha, L. A., John, S., & Gaffen, S. L. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328304b6b5 · Cited by 150
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 146
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Inflammatory bowel disease, past, present and future: lessons from animal models
Mizoguchi, A., & Mizoguchi, E. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2111-3 · Cited by 168
Th17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
van den Berg, W. B., & McInnes, I. B. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.006 · Cited by 155
“ACT1 mediates the recruitment of TNFR-associated factor (TRAF)6 and possibly of TRAF3, which are needed for activation of the canonical nuclear factor-κB (NF-κB) pathway [34,35].”
BackgroundNeuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies
Li, W., Wu, J., Zeng, Y., & Zheng, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269241 · Cited by 158
“The activating of IL-17 signal pathways may recruit adaptor molecule actin-related gene 1 (Act1) to the SEFIR domain of IL-17RA/C complex, subsequently recruit TNF receptor associated factor 6 (TRAF6) and activate a wide spectrum of pro-in fl ammatory signal pathways in brain (78).”
BackgroundThe Adaptor Protein CIKS/Act1 Is Essential for IL-25-Mediated Allergic Airway Inflammation
Claudio, E., Sønder, S. U., Saret, S., Carvalho, G., Ramalingam, T. R., Wynn, T. A., Chariot, A., Garcia-Perganeda, A., Leonardi, A., Paun, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1617 · Cited by 141
“After partial backcrossing to BL/6 mice, Act1 mutant mice were reported to have a delayed onset of B cell-mediated autoimmune phenotypes (20).”
BackgroundInfluentialZhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 138
Self-citationThe Critical Role of Epithelial-Derived Act1 in IL-17- and IL-25-Mediated Pulmonary Inflammation
Swaidani, S., Bulek, K., Kang, Z., Liu, C., Lu, Y., Yin, W., Aronica, M., & Li, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1631 · Cited by 138
“It is important to note that a recent study by Rickel et al. (36) demonstrated an essential role for IL-17RA in IL-25 (IL-17E) signaling through the IL-25R (IL-17RB), suggesting the possibility for heterodimerization of IL-17RA and IL-17RB in mediating IL-25 (IL-17E) signaling.”
BackgroundMethodInfluentialSelf-citationMajor Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
Bugaut, H., & Aractingi, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621956 · Cited by 151
Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation
Reynolds, J. M., Lee, Y.-H., Shi, Y., Wang, X., Angkasekwinai, P., Nallaparaju, K. C., Flaherty, S., Chang, S. H., Watarai, H., & Dong, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.008 · Cited by 135
“IL-25 induced IL-6, we next asked whether this effect was dependent on the IL-17RA and IL-17RB heterodimer as well as the Act1 adaptor, all of which are known to be required for IL-17RB signaling in other cells (Chang et al., 2006; Qian et al., 2007; Rickel et al., 2008; Claudio et al., 2009; Angkasekwinai et al., 201…”
BackgroundIL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 131
“Moreover, Act1-independent signals may contribute to the phosphorylation of C/EBPb because IL-17–mediated phosphorylation of ERK in Act1-deficient MEFs is greatly delayed compared with that in WT cells (14).”
BackgroundResultInfluentialCytokines and effector T cell subsets causing autoimmune CNS disease
Petermann, F., & Korn, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.064 · Cited by 128
“However, in contrast to IL-17RA and IL-17RC, the functional IL-22 receptor complex is not expressed on hematopoietic cells.”
BackgroundInfluentialDisturbance of cytokine networks in Sjögren's syndrome
Youinou, P., & Pers, J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3348 · Cited by 141
A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour
Ito, M., Nakashima, A., 日高, 隆., Okabe, M., Bac, N. D., Ina, S., Yoneda, S., Shiozaki, A., Sumi, S., Tsuneyama, K., et al. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.09.005 · Cited by 132
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
DeSelm, C. J., Takahata, Y., Warren, J., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24165 · Cited by 125
“Act1 is an adaptor protein required for IL-17’s induction of inflammatory cytokine expression [Qian et al., 2007].”
BackgroundSelf-citationHo, A. W., Shen, F., Conti, H. R., Patel, N., Childs, E. E., Peterson, A. C., Hernández-Santos, N., Kolls, J. K., Kane, L. P., Ouyang, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903739 · Cited by 125
“Structure-function studies subsequently showed that the IL-17RA SEFIR motif is critical for activation of IL-17A– dependent downstream effector pathways including the MAPK, NFkB, and C/EBP pathways (10, 12).”
InfluentialThe deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128
“The SEFIR domain is conserved among IL-17R family members and serves as a platform for its association with Act1, which in turn interacts with TRAF6 (19).”
BackgroundMethodInfluentialThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
Self-citationIL-17 is a neuromodulator of Caenorhabditis elegans sensory responses
Chen, C., Itakura, E., Nelson, G. M., Sheng, M., Laurent, P., Fenk, L. A., Butcher, R. A., Hegde, R. S., & de Bono, M. (2017) · Nature · doi:10.1038/nature20818 · Cited by 127
Regulation and pro‐inflammatory function of interleukin‐17 family cytokines
Dong, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00709.x · Cited by 125
“using Act1-deficient mice that IL-17-mediated inflammatory responses were indeed severely impaired in these mice (30).”
IL-17 signaling in host defense and inflammatory diseases
Qian, Y., Kang, Z., Liu, C., & Li, X. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.27 · Cited by 138
Self-citationWang, T., Sun, X., Zhao, J., Zhang, J., Zhu, H., Li, C., Gao, N., Yuan, J., Xu, D., Huang, F., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204228 · Cited by 134
“diseases, including rheumatoid arthritis (RA) [1–4].”
Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies
Yasmeen, F., Pirzada, R. H., Ahmad, B., Choi, B., & Choi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147666 · Cited by 153
“The therapeutic potential of STAT3 and gp130 are promising; however, their inhibition can induce side effects [205,206].”
BackgroundWang, C., Zhang, C.-J., Martin, B. N., Bulek, K., Kang, Z., Zhao, J., Bian, G., Carman, J. A., Gao, J., Dongre, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15508 · Cited by 117
“Act1 is a key adaptor molecular in IL-17 pathway and plays a very important role in IL-17 signal transduction 17 .”
Self-citationHaroon, F., Drögemüller, K., Händel, U., Brunn, A., Reinhold, D., Nishanth, G., Mueller, W., Trautwein, C., Ernst, M., Deckert, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001135 · Cited by 121
“and CD4 T cell infiltration to the spinal cord (4, 5).”
BackgroundHerjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0071-9 · Cited by 121
“Act1 (encoded by the gene TRAF3IP2, also known as CIKS) is an essential component in IL-17 signaling and also a member of the SEFIR protein family 10, 11, 12 .”
Self-citationTRAF Molecules in Inflammation and Inflammatory Diseases
Lalani, A., Zhu, S., Gokhale, S., Jin, J., & Xie, P. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0117-y · Cited by 132
Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis
Aggor, F. E. Y., Break, T. J., Trevejo-Nuñez, G., Whibley, N., Coleman, B. M., Bailey, R. D., Kaplan, D. H., Naglik, J. R., Shan, W., Shetty, A. C., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba0570 · Cited by 119
“In fact, IL-17 signaling in gut is generally more reparative than inflammatory (94–98), which is thought to explain why anti-IL-17 biologic therapies failed in treatment trials of Crohn’s disease (99).”
BackgroundTsai, H.-C., Velichko, S., Hung, L.-Y., & Wu, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/267971 · Cited by 117
“The direct interaction of Act1 and IL-17RA was demonstrated through coimmunoprecipitation experiments and shown to be dependent on the SEFIR domain [97, 98].”
BackgroundInfluentialTLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation
Zhang, C.-J., Jiang, M., Zhou, H., Liu, W., Wang, C., Kang, Z., Han, B., Zhang, Q., Chen, X., Xiao, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121901 · Cited by 121
“Active EAE and adoptive transfer (passive) EAE were induced and assessed as previously described by our group (2, 3, 37).”
Self-citationThe neuroprotective potential of carotenoids in vitro and in vivo
Manochkumar, J., Doss, C. G. P., El-Seedi, H. R., Efferth, T., & Ramamoorthy, S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153676 · Cited by 124
Animal models of IBD: linkage to human disease
Mizoguchi, A., & Mizoguchi, E. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.05.007 · Cited by 130
“In addition, the lack of an adaptor protein Act1 for IL-17R signaling protects mice from DSS-induced intestinal injury [63].”
BackgroundT helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease
Iclozan, C., Yu, Y., Liu, C., Liang, Y., Yi, T., Anasetti, C., & Yu, X. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.09.023 · Cited by 124
“Most likely, IL-17 serves as an important effector cytokine in the development of GVHD, because IL-17 has been shown to cause direct tissue damages [31], and neutralizing IL-17 markedly decreased skin and lung GVHD [16,28,32].”
BackgroundSelf-citationMuch More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 121
“Act1 is crucial for IL-17 signaling, and it acts as adaptor and as RNA-binding protein (RBP) by forming several ribonucleoprotein particles (RNPs) (69, 76, 77).”
BackgroundInfluentialThe Role of Airway Epithelial Cell Alarmins in Asthma
Whetstone, C. E., Ranjbar, M., Omer, H., Cusack, R. P., & Gauvreau, G. M. (2022) · Cells · doi:10.3390/cells11071105 · Cited by 118
Hildebrand, J. M., Yi, Z., Buchta, C. M., Poovassery, J., Stunz, L. L., & Bishop, G. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01055.x · Cited by 110
Lin, D., Li, L., Sun, Y., Wang, W., Wang, X., Yu, Y., Chen, X., & Xu, Y. (2014) · Immunology · doi:10.1111/imm.12395 · Cited by 110
Etemadi, N., Chopin, M., Anderton, H., Tanzer, M. C., Rickard, J. A., Abeysekera, W., Hall, C. M., Spall, S. K., Wang, B. H., Xiong, Y., et al. (2015) · eLife · doi:10.7554/elife.10592 · Cited by 114
Wang, C., Wu, L., Bulek, K., Martin, B. N., Zepp, J. A., Kang, Z., Liu, C., Herjan, T., Misra, S., Carman, J. A., et al. (2013) · Nature Immunology · doi:10.1038/ni.2479 · Cited by 107
“Although Act1 -/- mice are resistant to IL-17-dependent inflammation, such as EAE, we have previously reported that Act1 -/- mice develop spontaneous autoimmune phenotypes, including skin inflammation 20 , characterized by epidermal hyperplasia and cell infiltration.”
BackgroundInfluentialSelf-citationEpithelium: the interplay between innate and Th2 immunity
Bulek, K., Swaidani, S., Aronica, M. A., & Li, X. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2009.113 · Cited by 121
Self-citationNeural consequences of chronic sleep disruption
Zamore, Z. H., & Veasey, S. C. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.05.007 · Cited by 117
“Additionally, IL-1β and TNF-α can trigger the activation and translocation of NF-κB to the nucleus in astrocytes [87].”
BackgroundIL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells
Chen, X., Cai, G., Liu, C., Zhao, J., Gu, C., Wu, L., Hamilton, T. A., Zhang, C.-J., Ko, J., Zhu, L., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20171849 · Cited by 106
“While the deletion of SEF IR domain abolished the interaction of Act1 with the receptors (Qian et al., 2007; Liu et al., 2009), it had no impact on the interaction of TRAF4 with IL-17RA or IL17RC (Fig.”
BackgroundSelf-citationLambert, S., Hambro, C. A., Johnston, A., Stuart, P. E., Tsoi, L. C., Nair, R. P., & Elder, J. T. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.021 · Cited by 112
“TRAF3IP2 encodes Act1, an adaptor with ubiquitin ligase activity that connects the IL-17 receptor to downstream signaling pathways (Qian et al., 2007).”
BackgroundGlaucoma: from pathogenic mechanisms to retinal glial cell response to damage
Fernández‐Albarral, J. A., Ramirez, A. I., de Hoz, R., Matamoros, J. A., Salobrar‐García, E., Elvira‐Hurtado, L., López‐Cuenca, I., Sánchez-Puebla, L., Salazar, J. J., & Ramirez, J. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1354569 · Cited by 116
IL-17RC: a partner in IL-17 signaling and beyond
Ho, A. W., & Gaffen, S. L. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0185-0 · Cited by 104
“It is currently unknown whether Act1, TRAF6, or other signaling intermediates bind directly to IL-17RC.”
InfluentialMorrison, P. J., Ballantyne, S. J., & Kullberg, M. C. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03454.x · Cited by 116
Liang, J., Dai, W., Liu, C., Wen, Y., Chen, C., Xu, Y., Huang, S. M., Hou, S., Li, C., Chen, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202400206 · Cited by 134
Self-citationMurdoch, J. R., & Lloyd, C. M. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1775oc · Cited by 110
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Xie, S., Li, J., Wang, J. H., Wu, Q., Yang, P., Hsu, H.-C., Smythies, L. E., & Mountz, J. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903133 · Cited by 102
“The SEFIR domain in IL-17RA is essential for IL-17 signaling (10, 12, 13).”
BackgroundResultSuzukawa, M., Morita, H., Nambu, A., Arae, K., Shimura, E., Shibui, A., Yamaguchi, S., Suzukawa, K., Nakanishi, W., Oboki, K., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200461 · Cited by 105
“This suggests that IL-25, which can bind to IL-17RA (10), rather than IL-17A and IL-17F, may contribute to the responses.”
BackgroundInfluentialTRAF Regulation of IL-17 Cytokine Signaling
Swaidani, S., Liu, C., Zhao, J., Bulek, K., & Li, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01293 · Cited by 110
“Act1 is now known to be recruited to the IL-17 receptor complex in a manner dependent on the homotypic and heterotypic interactions between the SEFIR domains on Act1 as well as IL-17 receptors (21).”
BackgroundSelf-citationThe human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties
Goepfert, A., Lehmann, S., Wirth, E., & Rondeau, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08360-9 · Cited by 107
Human inborn errors of immunity underlying superficial or invasive candidiasis
Puel, A. (2020) · Human Genetics · doi:10.1007/s00439-020-02141-7 · Cited by 109
Interleukin-17 regulation: an attractive therapeutic approach for asthma
Park, S. J., & Lee, Y. C. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-78 · Cited by 111
“The expression of inflammation-related genes induced by IL-17 is abolished in Act1-deficient cells [41,42].”
BackgroundA tale of two cytokines: IL-17 and IL-22 in asthma and infection
Manni, M. L., Robinson, K. M., & Alcorn, J. F. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.854167 · Cited by 102
Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity
Mai, J. (2010) · Frontiers in Bioscience · doi:10.2741/3657 · Cited by 93
“In addition to TRAF6, TRAF3, and TAK1 are also involved in IL-17 signaling since the TRAF6 binding motif of ACT1 can bind to TRAF3 as well as TAK1 (122).”
BackgroundIL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology
Nies, J. F., & Panzer, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00341 · Cited by 104
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
Rasheed, M., Liang, J., Wang, C., Deng, Y., & Chen, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094956 · Cited by 101
“However, when IL17 was released, it bound to the heterologous transmembrane receptors, which led to the recruitment of NF-kB activator 1 (Act1) and the formation of signal complexes, thereby exhibiting the A1 phenotype and promoting the production of pro-inflammatory cytokines [26].”
BackgroundHuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization
Herjan, T., Yao, P., Qian, W., Li, X., Liu, C., Bulek, K., Sun, D., Yang, W.-P., Zhu, J., He, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203315 · Cited by 95
“Act1 (also known as CIKS) is an essential component in IL-17 signaling and required for IL-17– dependent immune responses (15, 18, 19).”
BackgroundSelf-citationTH17 cells in asthma and inflammation
Aujla, S. J., & Alcorn, J. F. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.002 · Cited by 104
IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6
Hartupee, J., Liu, C., Novotny, M., Sun, D., Li, X., & Hamilton, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1660 · Cited by 88
“Quantitative real-time PCR was performed, as previously described (21).”
InfluentialSelf-citationPrinz, I., Sandrock, I., & Mrowietz, U. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191397 · Cited by 91
Qu, F., Gao, H., Zhu, S., Shi, P., Zhang, Y., Liu, Y., Jallal, B., Yao, Y., Shi, Y., & Qian, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00268-12 · Cited by 87
“Act1 is identified as a key adaptor to recruit TRAF6 to IL-17R to mediate IL-17-induced NF- B activation, while TRAF3 and TRAF4 are found to interfere with the complex formation of IL-17R-Act1TRAF6 (3, 27, 37, 38).”
BackgroundSelf-citationBechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
Organizing structural principles of the IL-17 ligand–receptor axis
Wilson, S. C., Caveney, N. A., Yen, M., Pollmann, C., Xiang, X., Jude, K. M., Hafer, M., Tsutsumi, N., Piehler, J., & Garcia, K. C. (2022) · Nature · doi:10.1038/s41586-022-05116-y · Cited by 84
Toh, M., Gonzales, G., Koenders, M. I., Tournadre, A., Boyle, D., Lubberts, E., Zhou, Y., Firestein, G. S., van den Berg, W. B., & Miossec, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013416 · Cited by 90
“Cytokine induced ERK MAPK and Ets 1 transcription factor have been reported to control synoviolin expression in mouse cells [5].”
BackgroundInfluentialLiu, W. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.10.004 · Cited by 103
Dainichi, T., Matsumoto, R., Mostafa, A., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01107 · Cited by 96
Friedrich, M., Diegelmann, J., Schauber, J., Auernhammer, C. J., & Brand, S. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.124 · Cited by 91
“ACT1 is a necessary adaptor protein for IL-17Ainduced expression of inflammation-related gene targets.(47) Consequently, siRNA-mediated knockdown of ACT1 reversed the amplification of IL-17C mRNA expression by IL-17A (Figure 7a).”
BackgroundMoshaverinia, A., Chen, C., Xu, X., Ansari, S., Zadeh, H. H., Schricker, S. R., Paine, M. L., Moradian‐Oldak, J., Khademhosseini, A., Snead, M. L., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201500055 · Cited by 87
Liu, X., He, F., Pang, R., Zhao, D., Qiu, W., Shan, K., Zhang, J., Lu, Y., Li, Y., & Wang, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577429 · Cited by 83
“Mice were monitored daily for clinical signs of EAE and graded on a scale of increasing severity from 0 to 5, according to a previously published grading scale (21): 0, no clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of one or two hind limbs); 3, paraplegia (complete paralysis of two hi…”
MethodSelf-citationStructure and function of interleukin-17 family cytokines
Zhang, X., Angkasekwinai, P., Dong, C., & Tang, H. (2011) · Protein & Cell · doi:10.1007/s13238-011-1006-5 · Cited by 96
Th17 Cells in Periodontitis and Its Regulation by A20
Huang, N., Dong, H., Luo, Y., & Shao, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742925 · Cited by 100
“In a phase III, randomized double-blind placebo-controlled study using Brodalumab (a monoclonal antibody against IL-17RA) on moderate-to-severe plaque psoriasis, more than 70 percent of patients achieved a 75% reduction in psoriasis area severity index at 12 weeks, which is much higher than the placebo group (182).”
BackgroundInfluentialRole of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Nie, Y., Wu, S., Xuan, Y.-H., & Yan, G. (2022) · Military Medical Research · doi:10.1186/s40779-022-00382-3 · Cited by 103
IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence
Datta, S., Novotny, M., Pavicic, P. G., Zhao, C., Herjan, T., Hartupee, J., & Hamilton, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902423 · Cited by 82
“The magnitude of NFkB and the associated transcriptional response to IL-17 is, however, modest by comparison with other well-studied proinflammatory cytokine signals (6, 7).”
BackgroundResultSelf-citationZhang, J., Fu, Q., Ren, Z., Wang, Y., Wang, C., Shen, T., Wang, G., & Wu, L. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.975683 · Cited by 79
“First, the binding of IL-17 with its receptor activated two pathways, namely the NF-jB and mitogen-activated protein kinases (MAPKs) [24]; furthermore, Act-1, an activator of NF-jB pathway, is also required for IL-17-mediated signal transduction process [25,26].”
BackgroundClinical implication of recent advances in our understanding of IL-17 and reproductive immunology
Saito, S., Nakashima, A., Ito, M., & Shima, T. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.49 · Cited by 84
IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling
Rong, Z., Wang, A., Li, Z., Ren, Y., Cheng, L., Li, Y., Wang, Y., Ren, F., Zhang, X., Hu, J., et al. (2008) · Cell Research · doi:10.1038/cr.2008.320 · Cited by 86
Zhou, J., An, X., Dong, J., Wang, Y., Zhong, H., Duan, L., Ling, J., Ping, F., & Shang, J. (2018) · The FASEB Journal · doi:10.1096/fj.201701242rr · Cited by 85
“ACT1mediated signaling of IL-17R is required for the local IL-17–dependent production of proinflammatory cytokines by various types of cells during inflammation (31).”
BackgroundIL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination
Kang, Z., Liu, L., Spangler, R., Spear, C., Wang, C., Gulen, M. F., Veenstra, M., Ouyang, W., Ransohoff, R. M., & Li, X. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0841-12.2012 · Cited by 78
“We previously reported that Act1 is a key component in IL-17 signaling (Leonardi et al., 2000; Li et al., 2000; Qian et al., 2002, 2007).”
BackgroundSelf-citationZimmermann, J., Krauthausen, M., Hofer, M. J., Heneka, M. T., Campbell, I. L., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057307 · Cited by 75
“TRAF6 and the adaptor protein Act-1 signaling [39,40] thus leading to the expression of many proinflammatory cytokines,”
BackgroundBuckley, K. M., Ho, E. C. H., Hibino, T., Schrankel, C. S., Schuh, N. W., Wang, G., & Rast, J. P. (2017) · eLife · doi:10.7554/elife.23481 · Cited by 77
“The SEFIR domain mediates intracellular signaling through interactions with the adaptor molecule Act1, which also contains a SEFIR domain (Qian et al., 2007).”
BackgroundZepp, J. A., Liu, C., Qian, W., Wu, L., Gulen, M. F., Kang, Z., & Li, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200470 · Cited by 73
“Abs to TAK1 and mAct1 were described previously (6, 15).”
BackgroundMethodSelf-citationLuo, Q., Liu, Y., Shi, K., Shen, X., Yang, Y., Liang, X., Lu, L., Qiao, W., Chen, A., Hong, D., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.012 · Cited by 70
INTERLEUKIN-17 IN PULMONARY HOST DEFENSE
Aujla, S. J., Dubin, P. J., & Kolls, J. K. (2007) · Experimental Lung Research · doi:10.1080/01902140701756604 · Cited by 75
“Mice witha homozygous deletion of IL17RA show reduced levels of CXCL1 and CXCL2 in the lung upon challenge with the gram-negative bacteria K. pneumoniae [21].”
BackgroundInfluentialRoles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis
Deng, C., Peng, N., Tang, Y., Yu, N., Wang, C., Cai, X., Zhang, L., Hu, D., Ciccia, F., & Lu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691559 · Cited by 81
“Two tumor necrosis factor (TNF) receptor-associated factorbinding (TRAF-binding) sits are shown at the N terminus of Act1, therefore TRAF-containing proteins including TRAF3, TRAF6 and transforming growth factor b-activated kinase 1 (TGFb-activated kinase 1, TAK1) bind to IL-17R upon engagement (54).”
BackgroundIL-17C Is a Mediator of Respiratory Epithelial Innate Immune Response
Pfeifer, P., Voss, M., Wonnenberg, B., Hellberg, J., Seiler, F., Lepper, P. M., Bischoff, M., Langer, F., Schäfers, H., Menger, M. D., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0232oc · Cited by 75
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis
Crispino, N., & Ciccia, F. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/e7ayu8 · Cited by 73
“A SEFIR domain is also present in Act1, an adaptor protein with E3 ligase activity that orchestrates homotypic interactions with the SEFIR motif of the IL-17 receptors, mainly leading to TRAF6dependent activation of the NF-κB and MAP kinase pathways (36-41).”
BackgroundInterleukin‐17—A multifaceted cytokine in viral infections
Sahu, U., Biswas, D., Prajapati, V. K., Singh, A. K., Samant, M., & Khare, P. S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30471 · Cited by 80
Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia
Mellett, M., Atzei, P., Horgan, A., Hams, E., Floß, T., Wurst, W., Fallon, P. G., & Moynagh, P. N. (2012) · Nature Communications · doi:10.1038/ncomms2127 · Cited by 80
Kang, Z., Swaidani, S., Yin, W., Wang, C., Barlow, J. L., Gulen, M. F., Bulek, K., Do, J.-S., Aronica, M., McKenzie, A. N. J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.021 · Cited by 72
“Whereas Act1 is required for IL-17-dependent signaling and autoimmune inflammatory disease (Qian et al., 2007), Act1 deficiency abolishes IL-25-induced expression of Th2 cell-type cytokines and pulmonary eosinophilia (Claudio et al.”
BackgroundSelf-citationWu, N., Huang, D.-Y., Tsou, H.-N., Lin, Y., & Lin, W. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.383 · Cited by 75
TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
Xiao, Y., Jin, J., Chang, M., Nakaya, M., Hu, H., Zou, Q., Zhou, X., Brittain, G. C., Cheng, X., & Sun, S.-C. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132640 · Cited by 71
Compartmentalized Expression of Th1 and Th17 Cytokines in Pediatric Inflammatory Bowel Diseases
Verdier, J., Begue, B., Cerf-Bensussan, N., & Ruemmele, F. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21905 · Cited by 71
“IL-17A or IL-17F are likely to have an effect in colitis since mice deficient for the IL-17RA subunit or for its downstream adaptor Act1, which mediate the effects of both IL-17A and IL-17F,(13,14) are protected in the trinitrobenzenesulfonic acid (TNBS) and in the dextran sulfate sodium (DSS) models of colitis.(15,16…”
BackgroundTh17 Differentiation and Their Pro-inflammation Function
Song, X., Gao, H., & Qian, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_5 · Cited by 74
“After IL-17 stimulation, IL-17R recruited Act1 to its intracellular region through SEFIR-SEFIR domain interaction [27, 220].”
BackgroundSelf-citationAct1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li, X.-X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 78
Self-citation
Metadata
- Authors
- Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., Kordula, T., Zhang, Q.-W., Vallance, B., Swaidani, S., Aronica, M., Tuohy, V. K., Hamilton, T., & Li, X.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Virginia Commonwealth University (US)
- University of British Columbia (CA)
- Corresponding author
- Li, Xiaoxia
- ORCID
- Venue
- Nature Immunology
- Published
- 2007-02-04
- Volume
- 8
- Issue
- 3
- Pages
- 247-256
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2021674244
- Cited by
- 614
- References
- 45
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 32 · 2022: 37 · 2021: 41 · 2020: 23 · 2019: 30 · 2018: 25 · 2017: 25 · 2016: 21 · 2015: 26 · 2014: 31 · 2013: 38 · 2012: 33
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI065470, AI 065470)
- National Institute of Neurological Disorders and Stroke (R01-NS071996)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Act1, IL-17, IL-17 receptor signaling, TAK1, TRAF6, NF-κB activation, adaptor proteins, astrocytes, intestinal epithelial cells, autoimmune encephalomyelitis, DSS-induced colitis, inflammatory diseases, T helper cells
- MeSH terms
- Animals, Autoimmune Diseases, Colitis, Encephalomyelitis, Autoimmune, Experimental, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, T-Lymphocytes, Transfection, Signal Transduction, Autoimmunity, Gene Expression, CD40 Antigens, Adoptive Transfer, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-17, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, B-Cell Activation Factor Receptor, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.